WEST POINT, Pa. (AP) -- There's a not-so-secret ingredient used to make Merck & Co.'s new vaccine to prevent cervical cancer: common baker's yeast. But there's nothing simple about the manufacture and marketing of Gardasil, the first cervical-cancer vaccine approved by regulators. The Whitehouse Station, N.J., pharmaceutical giant expects Gardasil to become one of its best-selling products, and the company is making big changes to ensure its launch is successful. Adding to the challenge is that Gardasil is one of three new vaccines Merck has launched this year. The others are Rotateq, designed to prevent rotavirus in children, and Zostavax...